In colorectal cancer, classical Hodgkin lymphoma, nasopharyngeal carcinoma, breast tumors, head and neck squamous cell carcinoma, and glioblastoma, SEPT9 served as a tumor suppressor gene [14,16,17,18,19,20,21]. This evidence concerns the gene SEPTIN9 and breast neoplasm.